Publication | Closed Access
Silibinin, a novel chemokine receptor type 4 antagonist, inhibits chemokine ligand 12-induced migration in breast cancer cells
28
Citations
25
References
2014
Year
Breast OncologyMedicineBreast Cancer CellsBreast CancerAnti-cancer AgentCancer TreatmentPharmacologyCell BiologyTumor MicroenvironmentCancer Research
| Year | Citations | |
|---|---|---|
Page 1
Page 1